A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Number of shares, 3 months chart
Year | Volume (Price x Shares) | Change |
---|---|---|
2025 | C$28.73 M | 441.85% |
2024 | C$5.3 M | -52.79% |
2023 | C$11.23 M | 151.98% |
2022 | C$4.45 M | -68.48% |
2021 | C$14.14 M | -78.73% |
2020 | C$66.49 M | 326.35% |
2019 | C$15.59 M | 24.24% |
2018 | C$12.55 M | -45.49% |
2017 | C$23.02 M | -35.09% |
2016 | C$35.47 M | -36.68% |
2015 | C$56.02 M | 154.23% |
2014 | C$22.03 M | 233.35% |
2013 | C$6.61 M |
Company | FTD volume (3 months) | FTD volume (1 year) | Country |
---|---|---|---|
![]() Vertex Pharmaceuticals VRTX | C$21.98 M | C$73.33 M | ๐บ๐ธ USA |
![]() Sarepta Therapeutics
SRPT | C$11.68 M | C$23.74 M | ๐บ๐ธ USA |
![]() Fate Therapeutics
FATE | C$0.46 M | C$1.65 M | ๐บ๐ธ USA |
![]() Avidity Biosciences RNA | C$7.38 M | C$19.54 M | ๐บ๐ธ USA |
![]() Xencor XNCR | C$0.16 M | C$1.78 M | ๐บ๐ธ USA |
![]() Novartis NVS | C$8.82 M | C$0.15 B | ๐จ๐ญ Switzerland |